ABSTRACT
Purpose
Our objective was to determine the effect of the flavonoid biochanin A (BCA), administered alone or in combination with the flavonoids quercetin and epigallocatechin-3-gallate (EGCG), on the growth of human breast cancer MCF-7 cells in a murine xenograft animal model.
Materials and Methods
MCF-7 tumors were implanted into mice and groups of mice were treated with vehicle, BCA at 2 doses (5 or 15 mg/kg), quercetin and EGCG (5 mg/kg each), or BCA combined with quercetin and EGCG (5 mg/kg each). The flavonoids were injected once daily intraperitoneally, with treatment starting 4 weeks prior to cell inoculation.
Results
Treatment with 15 mg/kg of BCA or the mixture of the 3 flavonoids resulted in a reduction in tumor incidence. Tumor size in xenograft mice treated with 15 mg/kg BCA was significantly smaller than in the control group. Although quercetin/EGCG administration did not affect tumor size, treatment with the mixture of the 3 flavonoids at doses of 5 mg/kg produced similar effects as seen with 15 mg/kg BCA.
Conclusions
Our findings indicate that BCA inhibits tumor growth in a xenograft animal model; BCA may represent a breast cancer preventive agent, either administered alone or in combination with other flavonoids.
Abbreviations
- BCA:
-
biochanin A
- EGCG:
-
epigallocatechin-3-gallate
References
www.cancer.org. Cancer Statistics 2007, American Cancer Society, Inc. Available at: http://www.cancer.org/. (2007).
A. Brodie, Q. Lu, and J. Nakamura. Aromatase in the normal breast and breast cancer. J Steroid Biochem Mol Biol. 61:281–286 (1997).
C. A. Lamartiniere. Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr. 71:1705S–1707S; discussion 1708S–1709S (2000).
S. Barnes, G. Peterson, C. Grubbs, and K. Setchell. Potential role of dietary isoflavones in the prevention of cancer. Adv Exp Med Biol. 354:135–147 (1994).
C. E. Rufer, and S. E. Kulling. Antioxidant activity of isoflavones and their major metabolites using different in vitro assays. J Agric Food Chem. 54:2926–2931 (2006).
A. Kalayciyan, H. Orawa, S. Fimmel, F. H. Perschel, J. B. Gonzalez, R. G. Fitzner, C. E. Orfanos, and C. C. Zouboulis. Nicotine and biochanin A, but not cigarette smoke, induce anti-inflammatory effects on keratinocytes and endothelial cells in patients with Behcet's disease. J Invest Dermatol. 127:81–89 (2007).
S. Puli, J. C. Lai, and A. Bhushan. Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones. J Neurooncol. 79:135–142 (2006).
T. Gotoh, K. Yamada, H. Yin, A. Ito, T. Kataoka, and K. Dohi. Chemoprevention of N-nitroso-N-methylurea-induced rat mammary carcinogenesis by soy foods or biochanin A. Jpn J Cancer Res. 89:137–142 (1998).
Y. S. Lee, J. S. Seo, H. T. Chung, and J. J. Jang. Inhibitory effects of biochanin A on mouse lung tumor induced by benzo(a)pyrene. J Korean Med Sci. 6:325–328 (1991).
J. M. Cassady, T. M. Zennie, Y. H. Chae, M. A. Ferin, N. E. Portuondo, and W. M. Baird. Use of a mammalian cell culture benzo(a)pyrene metabolism assay for the detection of potential anticarcinogens from natural products: inhibition of metabolism by biochanin A, an isoflavone from Trifolium pratense L. Cancer Res. 48:6257–6261 (1988).
Y. J. Moon, D. A. Brazeau, and M. E. Morris. Effects of flavonoids genistein and biochanin A on gene expression and their metabolism in human mammary cells. Nutr Cancer. 57:48–58 (2007).
L. Rice, V. G. Samedi, T. A. Medrano, C. A. Sweeney, H. V. Baker, A. Stenstrom, J. Furman, and K. T. Shiverick. Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts. Prostate. 52:201–212 (2002).
K. Yanagihara, A. Ito, T. Toge, and M. Numoto. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res. 53:5815–5821 (1993).
C. Ying, J. T. Hsu, and S. C. Shieh. Growth inhibition of human endothelial cells by the phyto-oestrogen biochanin A, a metabolite of genistein. Br J Nutr. 85:615–620 (2001).
J. T. Hsu, H. C. Hung, C. J. Chen, W. L. Hsu, and C. Ying. Effects of the dietary phytoestrogen biochanin A on cell growth in the mammary carcinoma cell line MCF-7. J Nutr Biochem. 10:510–517 (1999).
T. G. Peterson, L. Coward, M. Kirk, C. N. Falany, and S. Barnes. The role of metabolism in mammary epithelial cell growth inhibition by the isoflavones genistein and biochanin A. Carcinogenesis. 17:1861–1869 (1996).
J. R. Zhou, L. Yu, Z. Mai, and G. L. Blackburn. Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice. Int J Cancer. 108:8–14 (2004).
A. Murakami, D. Takahashi, K. Koshimizu, and H. Ohigashi. Synergistic suppression of superoxide and nitric oxide generation from inflammatory cells by combined food factors. Mutat Res. 523–524:151–161 (2003).
M. Mouria, A. S. Gukovskaya, Y. Jung, P. Buechler, O. J. Hines, H. A. Reber, and S. J. Pandol. Food–derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int J Cancer. 98:761–769 (2002).
F. V. So, N. Guthrie, A. F. Chambers, M. Moussa, and K. K. Carroll. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer. 26:167–181 (1996).
K. B. Horwitz, M. E. Costlow, and W. L. McGuire. MCF-7; a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors. Steroids. 26:785–795 (1975).
C. Ying, J. T. Hsu, H. C. Hung, D. H. Lin, L. F. Chen, and L. K. Wang. Growth and cell cycle regulation by isoflavones in human breast carcinoma cells. Reprod Nutr Dev. 42:55–64 (2002).
S. T. Willard, and L. S. Frawley. Phytoestrogens have agonistic and combinatorial effects on estrogen-responsive gene expression in MCF-7 human breast cancer cells. Endocrine. 8:117–121 (1998).
H. Farhan, K. Wahala, H. Adlercreutz, and H. S. Cross. Isoflavonoids inhibit catabolism of vitamin D in prostate cancer cells. J Chromatogr B Analyt Technol Biomed Life Sci. 777:261–268 (2002).
M. S. Morton, P. S. Chan, C. Cheng, N. Blacklock, A. Matos-Ferreira, L. Abranches-Monteiro, R. Correia, S. Lloyd, and K. Griffiths. Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate. 32:122–128 (1997).
Y. J. Moon and M. E. Morris. Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: Effects of quercetin and EGCG on biochanin A disposition in rats. Mol Pharm 4:865–872 (2007).
A. C. Pike, A. M. Brzozowski, R. E. Hubbard, T. Bonn, A. G. Thorsell, O. Engstrom, J. Ljunggren, J. A. Gustafsson, and M. Carlquist. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. Embo J. 18:4608–4618 (1999).
M. Lacey, J. Bohday, S. M. Fonseka, A. I. Ullah, and S. A. Whitehead. Dose-response effects of phytoestrogens on the activity and expression of 3beta-hydroxysteroid dehydrogenase and aromatase in human granulosa-luteal cells. J Steroid Biochem Mol Biol. 96:279–286 (2005).
N. R. Bianco, L. J. Chaplin, and M. M. Montano. Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage. Biochem J. 385:279–287 (2005).
X. Y. Sun, C. A. Plouzek, J. P. Henry, T. T. Wang, and J. M. Phang. Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cells. Cancer Res. 58:2379–2384 (1998).
Y. J. Moon, K. Sagawa, K. Frederick, S. Zhang, and M. E. Morris. Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats. AAPS J. 8:E433–442 (2006).
X. Jia, J. Chen, H. Lin, and M. Hu. Disposition of flavonoids via enteric recycling: enzyme-transporter coupling affects metabolism of biochanin A and formononetin and excretion of their phase II conjugates. J Pharmacol Exp Ther. 310:1103–1113 (2004).
M. H. Choi, K. R. Kim, J. K. Hong, S. J. Park, and B. C. Chung. Determination of non-steroidal estrogens in breast milk, plasma, urine and hair by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 16:2221–2228 (2002).
K. D. Setchell, N. M. Brown, P. Desai, L. Zimmer-Nechemias, B. E. Wolfe, W. T. Brashear, A. S. Kirschner, A. Cassidy, and J. E. Heubi. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr. 131:1362S–1375S (2001).
J. Howes, M. Waring, L. Huang, and L. G. Howes. Long-term pharmacokinetics of an extract of isoflavones from red clover (Trifolium pratense). J Altern Complement Med. 8:135–142 (2002).
M. J. Messina, and C. L. Loprinzi. Soy for breast cancer survivors: a critical review of the literature. J Nutr. 131:3095S–3108S (2001).
H. Mizunuma, K. Kanazawa, S. Ogura, S. Otsuka, and H. Nagai. Anticarcinogenic effects of isoflavones may be mediated by genistein in mouse mammary tumor virus-induced breast cancer. Oncology. 62:78–84 (2002).
ACKNOWLEDGEMENT
This study was supported by grants from the Susan G. Komen and Cancer Research and Prevention Foundations. We thank Drs. Atif Awad and Carol Fink for their assistance with the murine xenograft model.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moon, Y.J., Shin, B.S., An, G. et al. Biochanin A Inhibits Breast Cancer Tumor Growth in A Murine Xenograft Model. Pharm Res 25, 2158–2163 (2008). https://doi.org/10.1007/s11095-008-9583-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-008-9583-6